SGHTSight Sciences, Inc.

$224M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M+0.7% YoY

Gross Profit

$17M83.9% margin

Operating Income

-$11M-55.7% margin

Net Income

-$11M-54.9% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-5.7%

Cash Flow

Operating Cash Flow

$600,000

Free Cash Flow

$549,000

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$144M

Total Liabilities

$49M

Stockholders' Equity

$95M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$20M	+0.7%
Gross Profit	$17M	$17M	-2.5%
Operating Income	-$11M	-$13M	+16.3%
Net Income	-$11M	-$13M	+15.1%

Revenue Segments

Surgical Glaucoma

$19M92%

Dry Eye

$2M8%

SGHT Q3 2024 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena